ACTINIUM PHARMACEUTICALS, INC.
Profit History
| Period | Revenue | Operating Income | Net Income |
|---|---|---|---|
| Mar 2017 | — | $-7.8M | $-8.1M |
| Jun 2017 | — | $-7.2M | $-7.1M |
| Sep 2017 | — | $-6.7M | $-6.3M |
| Mar 2018 | — | $-6.4M | $-6.3M |
| Jun 2018 | — | $-4.9M | $-4.9M |
| Sep 2018 | — | $-6.2M | $-6.1M |
| Mar 2019 | — | $-5.7M | $-5.7M |
| Jun 2019 | — | $-5.1M | $-5.0M |
| Sep 2019 | — | $-6.7M | $-6.6M |
| Mar 2020 | — | $-5.7M | $-5.7M |
| Jun 2020 | — | $-4.7M | $-4.6M |
| Sep 2020 | — | $-5.6M | $-5.5M |
| Mar 2021 | $622.0K | $-5.4M | $-5.3M |
| Jun 2021 | $266.0K | $-5.1M | $-5.0M |
| Sep 2021 | $233.0K | $-6.5M | $-6.4M |
| Mar 2022 | $940.0K | $-5.2M | $-5.1M |
| Jun 2022 | $45.0K | $-7.9M | $-7.8M |
| Sep 2022 | $45.0K | $-9.8M | $-9.5M |
| Mar 2023 | — | $-11.6M | $-11.0M |
| Jun 2023 | — | $-15.6M | $-15.2M |
| Sep 2023 | — | $-14.4M | $-13.3M |
| Mar 2024 | — | $-9.6M | $-8.7M |
| Jun 2024 | — | $-12.4M | $-11.4M |
| Sep 2024 | — | $-12.6M | $-11.6M |
| Mar 2025 | — | $-16.6M | $-15.9M |
| Jun 2025 | — | $-7.5M | $-6.9M |
| Sep 2025 | $90.0K | $-5.7M | $-5.1M |
| Mar 2026 | — | $-5.9M | $-5.5M |
| Jun 2026 | $35.0M | $27.6M | $27.9M |